Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strain
Rohde, C., Resch, G., Pirnay, J.-P., Blasdel, B. G., Debarbieux, L., Gelman, D., Górski, A., Hazan, R., Huys, I., Kakabadze, E., Łobocka, M., Maestri, A., De Freitas Almeida, G., Makalatia, K., Malik, D. J., Mašlaňová, I., Merabishvili, M., Pantucek, R., Rose, T., . . . Chanishvili, N. (2018). Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strain. Viruses, 10(4), Article 178. https://doi.org/10.3390/v10040178
Julkaistu sarjassa
VirusesTekijät
Päivämäärä
2018Oppiaine
Solu- ja molekyylibiologiaBiologisten vuorovaikutusten huippututkimusyksikköNanoscience CenterCell and Molecular BiologyCentre of Excellence in Biological Interactions ResearchNanoscience CenterTekijänoikeudet
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This is an open access article distributed under the terms of the Creative Commons License.
2018:116 | 2019:43 | 2020:64 | 2021:47 | 2022:40 | 2023:69 | 2024:53 | 2025:5
Phage therapy is increasingly put forward as a “new” potential tool in the fight against antibiotic resistant infections. During the “Centennial Celebration of Bacteriophage Research” conference in Tbilisi, Georgia on 26–29 June 2017, an international group of phage researchers committed to elaborate an expert opinion on three contentious phage therapy related issues that are hampering clinical progress in the field of phage therapy. This paper explores and discusses bacterial phage resistance, phage training and the presence of prophages in bacterial production strains while reviewing relevant research findings and experiences. Our purpose is to inform phage therapy stakeholders such as policy makers, officials of the competent authorities for medicines, phage researchers and phage producers, and members of the pharmaceutical industry. This brief also points out potential avenues for future phage therapy research and development as it specifically addresses those overarching questions that currently call for attention whenever phages go into purification processes for application.
...
Julkaisija
MDPIISSN Hae Julkaisufoorumista
1999-4915Asiasanat
Julkaisu tutkimustietojärjestelmässä
https://converis.jyu.fi/converis/portal/detail/Publication/27997599
Metadata
Näytä kaikki kuvailutiedotKokoelmat
Lisenssi
Ellei muuten mainita, aineiston lisenssi on © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This is an open access article distributed under the terms of the Creative Commons License.
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Adapting a Phage to Combat Phage Resistance
Laanto, Elina; Mäkelä, Kati; Hoikkala, Ville; Ravantti, Janne J.; Sundberg, Lotta-Riina (MDPI, 2020)Phage therapy is becoming a widely recognized alternative for fighting pathogenic bacteria due to increasing antibiotic resistance problems. However, one of the common concerns related to the use of phages is the evolution ... -
Counteracting the horizontal spread of bacterial antibiotic resistance with conjugative plasmid-dependent bacteriophages
Ojala, Ville (University of Jyväskylä, 2016) -
Microencapsulation of Enteric Bacteriophages in a pH-Responsive Solid Oral Dosage Formulation Using a Scalable Membrane Emulsification Process
Vinner, Gurinder K.; Richards, Kerry; Leppänen, Miika; Sagona, Antonia P.; Malik 1, Danish J. (MDPI, 2019)A scalable low-shear membrane emulsification process was used to produce microencapsulated Escherichia coli-phages in a solid oral dosage form. Uniform pH-responsive composite microparticles (mean size ~100 µm) composed ... -
Small things matter : of phages and antibiotic resistance conferring plasmids
Mattila, Sari (University of Jyväskylä, 2016)Viruses and plasmids are small units of genetic material dependent on cells either transiently or continuously. Intriguingly, stories of these small entities intertwine in antibiotic resistance crisis. Horizontal gene ... -
Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host
Mikonranta, Lauri; Buckling, Angus; Jalasvuori, Matti; Raymond, Ben (Royal Society Publishing, 2019)Phage therapy is attracting growing interest among clinicians as antibiotic resistance continues becoming harder to control. However, clinical trials and animal model studies on bacteriophage treatment are still scarce and ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.